These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 38259493)

  • 41. Nintedanib Ameliorates Bleomycin-Induced Pulmonary Fibrosis, Inflammation, Apoptosis, and Oxidative Stress by Modulating PI3K/Akt/mTOR Pathway in Mice.
    Pan L; Cheng Y; Yang W; Wu X; Zhu H; Hu M; Zhang Y; Zhang M
    Inflammation; 2023 Aug; 46(4):1531-1542. PubMed ID: 37160579
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Necrostatin-1 Alleviates Bleomycin-Induced Pulmonary Fibrosis and Extracellular Matrix Expression in Interstitial Pulmonary Fibrosis.
    Mou F; Mou C
    Med Sci Monit; 2020 Feb; 26():e919739. PubMed ID: 32019905
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Buyang Huanwu decoction ameliorates bleomycin-induced pulmonary fibrosis in rats by attenuating the apoptosis of alveolar type II epithelial cells mediated by endoplasmic reticulum stress.
    Zhou P; Wu X; Chen K; Du J; Wang F
    J Ethnopharmacol; 2024 Jan; 319(Pt 3):117300. PubMed ID: 37813290
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Selective depletion of CD11b-positive monocytes/macrophages potently suppresses bleomycin-induced pulmonary fibrosis.
    Wan X; Xiao Y; Tian X; Lu Y; Chu H
    Int Immunopharmacol; 2023 Jan; 114():109570. PubMed ID: 36700767
    [TBL] [Abstract][Full Text] [Related]  

  • 45. An Herbal Product Alleviates Bleomycin-Induced Pulmonary Fibrosis in Mice via Regulating NF-κB/TNF-α Signaling in Macrophages.
    Jing F; Chen X; Xue J; Huang K; Xing F; Hu X; Peng Y; Liu C
    Front Pharmacol; 2022; 13():805432. PubMed ID: 35548340
    [No Abstract]   [Full Text] [Related]  

  • 46. Transcriptomic and proteomic profiling of young and old mice in the bleomycin model reveals high similarity.
    Klee S; Picart-Armada S; Wenger K; Birk G; Quast K; Veyel D; Rist W; Violet C; Luippold A; Haslinger C; Thomas M; Fernandez-Albert F; Kästle M
    Am J Physiol Lung Cell Mol Physiol; 2023 Mar; 324(3):L245-L258. PubMed ID: 36625483
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Underlying Molecular Mechanism and Construction of a miRNA-Gene Network in Idiopathic Pulmonary Fibrosis by Bioinformatics.
    Zheng S; Zhang Y; Hou Y; Li H; He J; Zhao H; Sun X; Liu Y
    Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686108
    [TBL] [Abstract][Full Text] [Related]  

  • 48. CoQ10 enhances the efficacy of airway basal stem cell transplantation on bleomycin-induced idiopathic pulmonary fibrosis in mice.
    Liu H; Liu S; Jiang J; Zhang Y; Luo Y; Zhao J; Xu J; Xie Y; Liao W; Wang W; Nie Y; Li S; Deng W
    Respir Res; 2022 Feb; 23(1):39. PubMed ID: 35219329
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Integrated RNA-sequencing and network pharmacology approach reveals the protection of Yiqi Huoxue formula against idiopathic pulmonary fibrosis by interfering with core transcription factors.
    Li H; Zhao C; Muhetaer G; Guo L; Yao K; Zhang G; Ji Y; Xing S; Zhou J; Huang X
    Phytomedicine; 2022 Sep; 104():154301. PubMed ID: 35792448
    [TBL] [Abstract][Full Text] [Related]  

  • 50. M2 macrophages induce EMT through the TGF-β/Smad2 signaling pathway.
    Zhu L; Fu X; Chen X; Han X; Dong P
    Cell Biol Int; 2017 Sep; 41(9):960-968. PubMed ID: 28493530
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ginsenoside Rb1 Alleviates Bleomycin-Induced Pulmonary Inflammation and Fibrosis by Suppressing Central Nucleotide-Binding Oligomerization-, Leucine-Rich Repeat-, and Pyrin Domains-Containing Protein Three Inflammasome Activation and the NF-κB Pathway.
    Liu J; Fan G; Tao N; Feng F; Meng C; Sun T
    Drug Des Devel Ther; 2022; 16():1793-1809. PubMed ID: 35719213
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Zanubrutinib attenuates bleomycin-induced pulmonary fibrosis by inhibiting the TGF-β1 signaling pathway.
    Chen S; Wei Y; Li S; Miao Y; Gu J; Cui Y; Liu Z; Liang J; Wei L; Li X; Zhou H; Yang C
    Int Immunopharmacol; 2022 Dec; 113(Pt A):109316. PubMed ID: 36252483
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Baccatin III ameliorates bleomycin-induced pulmonary fibrosis via suppression of TGF-β1 production and TGF-β1-induced fibroblast differentiation.
    Nie Y; Zhang D; Qian F; Wu Y
    Int Immunopharmacol; 2019 Sep; 74():105696. PubMed ID: 31229901
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Niclosamide-loaded nanoparticles (Ncl-NPs) reverse pulmonary fibrosis in vivo and in vitro.
    Gan C; Wang Y; Xiang Z; Liu H; Tan Z; Xie Y; Yao Y; Ouyang L; Gong C; Ye T
    J Adv Res; 2023 Sep; 51():109-120. PubMed ID: 36347425
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The gene expression of CALD1, CDH2, and POSTN in fibroblast are related to idiopathic pulmonary fibrosis.
    Wu S; Liu M; Zhang M; Ye X; Gu H; Jiang C; Zhu H; Ye X; Li Q; Huang X; Cao M
    Front Immunol; 2024; 15():1275064. PubMed ID: 38370408
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Oxymatrine attenuates bleomycin-induced pulmonary fibrosis in mice via the inhibition of inducible nitric oxide synthase expression and the TGF-β/Smad signaling pathway.
    Liu L; Lu W; Ma Z; Li Z
    Int J Mol Med; 2012 May; 29(5):815-22. PubMed ID: 22367596
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Role of lung apolipoprotein A-I in idiopathic pulmonary fibrosis: antiinflammatory and antifibrotic effect on experimental lung injury and fibrosis.
    Kim TH; Lee YH; Kim KH; Lee SH; Cha JY; Shin EK; Jung S; Jang AS; Park SW; Uh ST; Kim YH; Park JS; Sin HG; Youm W; Koh ES; Cho SY; Paik YK; Rhim TY; Park CS
    Am J Respir Crit Care Med; 2010 Sep; 182(5):633-42. PubMed ID: 20463180
    [TBL] [Abstract][Full Text] [Related]  

  • 58. AAV6-Mediated IL-10 Expression in the Lung Ameliorates Bleomycin-Induced Pulmonary Fibrosis in Mice.
    Kurosaki F; Uchibori R; Sehara Y; Saga Y; Urabe M; Mizukami H; Hagiwara K; Kume A
    Hum Gene Ther; 2018 Nov; 29(11):1242-1251. PubMed ID: 29598007
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The heterodimer S100A8/A9 is a potent therapeutic target for idiopathic pulmonary fibrosis.
    Araki K; Kinoshita R; Tomonobu N; Gohara Y; Tomida S; Takahashi Y; Senoo S; Taniguchi A; Itano J; Yamamoto KI; Murata H; Suzawa K; Shien K; Yamamoto H; Okazaki M; Sugimoto S; Ichimura K; Nishibori M; Miyahara N; Toyooka S; Sakaguchi M
    J Mol Med (Berl); 2021 Jan; 99(1):131-145. PubMed ID: 33169236
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cuproptosis-related gene CDKN2A as a molecular target for IPF diagnosis and therapeutics.
    Xu B; Yang K; Han X; Hou J
    Inflamm Res; 2023 Jun; 72(6):1147-1160. PubMed ID: 37166466
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.